Physician

Catherine Victoria Kulick, MD

According to 2025 Medicare claims, Catherine Kulick, MD (NPI: 1235626904) practices epileptologists in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1164810271; TIN: 232743545) and primary practice location at 19104-4208.

Kulick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 160 traditional Medicare patients, billed 525 HCPCS/CPT codes, and received $28,534 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 228 prescription claims across 58 beneficiaries totaling $28,455 in drug costs, led by Lacosamide (Lacosamide). Open Payments data shows 4 records totaling $504. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,380 and ending at $28,455. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$14K$29K2023 Medicare payment: $5,723 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $28,534 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20234661$5,723
2024160525$28,534

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$45K$90K2018 Drug cost: $5,380 (USD; Tot_Drug_Cst)2019 Drug cost: $8,153 (USD; Tot_Drug_Cst)2020 Drug cost: $89,618 (USD; Tot_Drug_Cst)2021 Drug cost: $59,762 (USD; Tot_Drug_Cst)2022 Drug cost: $16,683 (USD; Tot_Drug_Cst)2023 Drug cost: $20,124 (USD; Tot_Drug_Cst)2024 Drug cost: $28,455 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182878$5,380
201944118$8,153
202030178$89,618
202129158$59,762
202221164$16,683
202325142$20,124
202458228$28,455

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95720Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional3563$159
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more1919$106
95718Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional1820$106
95816Measurement of brain wave activity (eeg), awake and drowsy3636$45
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's2222$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LacosamideLacosamide512,804$7,156
ClobazamClobazam11810$2,412
Carbamazepine ErCarbamazepine12360$1,112
Levetiracetam ErLevetiracetam161,140$1,093
LevetiracetamLevetiracetam312,340$847

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$504Neurelis, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Catherine Victoria Kulick, MD?

Tedicare shows public-source Medicare data for Catherine Victoria Kulick, MD (NPI 1235626904), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Catherine Victoria Kulick, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Catherine Victoria Kulick, MD?

Catherine Victoria Kulick, MD is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1164810271) in the available physician profile data.

Does Catherine Victoria Kulick, MD have Open Payments data?

Catherine Victoria Kulick, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.